Compass Therapeutics (CMPX) Leases (2023 - 2025)
Historic Leases for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to $9.5 million.
- Compass Therapeutics' Leases rose 3600.0% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 3600.0%. This contributed to the annual value of $6.7 million for FY2024, which is 27899.77% up from last year.
- Per Compass Therapeutics' latest filing, its Leases stood at $9.5 million for Q3 2025, which was up 3600.0% from $9.8 million recorded in Q2 2025.
- Compass Therapeutics' Leases' 5-year high stood at $9.8 million during Q2 2025, with a 5-year trough of $1.2 million in Q2 2024.
- Over the past 3 years, Compass Therapeutics' median Leases value was $2.7 million (recorded in 2023), while the average stood at $4.6 million.
- Its Leases has fluctuated over the past 5 years, first tumbled by 5165.62% in 2024, then surged by 75030.36% in 2025.
- Compass Therapeutics' Leases (Quarter) stood at $1.8 million in 2023, then skyrocketed by 279.0% to $6.7 million in 2024, then soared by 40.42% to $9.5 million in 2025.
- Its last three reported values are $9.5 million in Q3 2025, $9.8 million for Q2 2025, and $6.5 million during Q1 2025.